Domov › Ťažká depresívna porucha › Washington
Klinické štúdie Ťažká depresívna porucha v štáte Washington
21 štúdií pre Ťažká depresívna porucha hľadá účastníkov v zariadeniach v štáte Washington.
Mestá v štáte Washington
Oficiálny text štúdie (anglicky)
A Study of Brenipatide (LY3537031) in Adult Participants With Major Depressive Disorder
- Northwest Clinical Research Center, Bellevue
Prebieha náborFáza 3
Vek 18 až 75 · Všetky pohlavia · Aktualizované 1. 10. 2026 · NCT07775300A Study of Seltorexant as Monotherapy in Adults and Elderly Participants With Major Depressive Disorder
- Northwest Clinical Research Center, Bellevue
Prebieha náborFáza 3
Vek 18 až 74 · Všetky pohlavia · Aktualizované 1. 10. 2026 · NCT07573176Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms
- Core Clinical Research, Everett
Prebieha náborFáza 3
Vek 18 až 74 · Všetky pohlavia · Aktualizované 25. 9. 2026 · NCT06559306Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder
- Northwest Clinical Research Center, Bellevue
Prebieha náborFáza 3
Vek 18 až 65 · Všetky pohlavia · Aktualizované 25. 9. 2026 · NCT05850689A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder
- Core Clinical Research, Everett
- Seattle Neuropsychiatric Treatment Center, Seattle
Prebieha náborFáza 3
Vek 18 až 85 · Všetky pohlavia · Aktualizované 25. 9. 2026 · NCT06793397Evaluation of Efficacy and Safety of Milsaperidone as Adjunctive Therapy in Patients With Major Depressive Disorder
- Vanda Investigational Site, Bellevue
Prebieha náborFáza 3
Vek 18 až 65 · Všetky pohlavia · Aktualizované 24. 9. 2026 · NCT06830044A Study to Evaluate the Efficacy and Safety of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 Study)
- Seaport Investigator Site, Everett
Prebieha náborFáza 2
Vek 18 až 65 · Všetky pohlavia · Aktualizované 14. 9. 2026 · NCT07065240A Study to Evaluate the Effectiveness of DT-101 as an Adjunctive Treatment in Patients With Depression
- Draig Clinical Site, Bellevue
- Draig Clinical Site, Seattle
Prebieha náborFáza 2
Vek 18 až 75 · Všetky pohlavia · Aktualizované 2. 9. 2026 · NCT07610473A Study to Evaluate the Effectiveness of DT-101 in Patients With Depression
- Draig Clinical Site, Bellevue
Prebieha náborFáza 2
Vek 18 až 75 · Všetky pohlavia · Aktualizované 26. 8. 2026 · NCT07300969Positive Processes and Transition to Health (PATH)
- University of Washington, Seattle
Prebieha nábor
Vek 18 až 65 · Všetky pohlavia · Aktualizované 19. 8. 2026 · NCT06093906Psilocybin Intervention for Veterans Overcoming Treatment-Resistant Depression
- VA Puget Sound Health Care System Seattle Division, Seattle, WA, Seattle
Prebieha náborFáza 3
Vek 18 až 75 · Všetky pohlavia · Aktualizované 14. 8. 2026 · NCT07226232A Phase 3 Trial of DT120 for Major Depressive Disorder (Ascend)
- Seattle Neuropsychiatric Treatment Center, Seattle
- VA Portland Healthcare System, Vancouver
Prebieha náborFáza 3
Vek 18 až 74 · Všetky pohlavia · Aktualizované 10. 8. 2026 · NCT07592689A Study of Brenipatide in Adult Participants With Major Depressive Disorder
- Northwest Clinical Research Center, Bellevue
Prebieha náborFáza 3
Vek 18 až 75 · Všetky pohlavia · Aktualizované 6. 8. 2026 · NCT07412756A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder
- Core Clinical Research, Everett
Prebieha náborFáza 3
Vek 18 až 74 · Všetky pohlavia · Aktualizované 3. 8. 2026 · NCT06775379Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
- Neurocrine Clinical Site, Everett
Prebieha náborFáza 3
Vek 18 a viac · Všetky pohlavia · Aktualizované 24. 7. 2026 · NCT06966401A Study to Assess Change in Disease Activity and Adverse Events of Oral Icalcaprant in Adult Participants With Major Depressive Disorder
- Northwest Clinical Research Center /ID# 277484, Bellevue
- Core Clinical Research /ID# 277518, Everett
Prebieha náborFáza 2
Vek 18 až 65 · Všetky pohlavia · Aktualizované 15. 6. 2026 · NCT07276997A Study to Assess the Efficacy, Safety and Tolerability of VLS-01 Buccal Film, Compared to Placebo in Patients With Treatment Resistant Depression (ELUMINA)
- Seattle Neuropsychiatric Treatment Center, Bellevue
Prebieha náborFáza 2
Vek 18 až 65 · Všetky pohlavia · Aktualizované 11. 5. 2026 · NCT06524830Study of ABX-002 for the Adjunctive Treatment of Major Depressive Disorder (AMPLIFY)
- Autobahn Site #143, Bellevue
Prebieha náborFáza 2
Vek 18 až 65 · Všetky pohlavia · Aktualizované 20. 1. 2026 · NCT06633016Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
- Neurocrine Clinical Site, Everett
Prebieha náborFáza 3
Vek 18 a viac · Všetky pohlavia · Aktualizované 29. 10. 2025 · NCT06786624A Study to Evaluate the Efficacy of AXS-05 Compared to Bupropion in Preventing the Relapse of Depressive Symptoms
- Clinical Research Site, Everett
Prebieha náborFáza 4
Vek 18 až 65 · Všetky pohlavia · Aktualizované 23. 1. 2025 · NCT06223880InMotion - Telehealth Delivered Exercise Promotion to Treat Major Depression After TBI
- University of Washington Medical Center, Seattle
Prebieha nábor
Vek 18 až 64 · Všetky pohlavia · Aktualizované 19. 9. 2024 · NCT06005194Z ClinicalTrials.gov, dáta načítané 5. 10. 2026. Každá štúdia má vlastné kritériá oprávnenosti; tím štúdie rozhoduje o účasti.